References
[1] Giasuddin, A. S. M. (2017). Role of immunologists in the development of health care system. Journal of Immunology and Immunotherapy, 1(1), 2. http//www.imedpub.com/articles.
[2] Greenberg S. A concise history of immunology. www.columbia.edu/itc/hs/medical.../immunology/.../ConcisehistoryImmun ology.pdf. (Retrieved 03 July 2018).
[3] Chappel, H., Haeney, M., Mishbah, S., and Sowden, N. (eds.). (2014). Essential of clinical immunology, 6th edition; Oxford: Wiley Blackwell; 2014. (www.wiley.com/wiley-blackwell).
[4] Donati, C. and Rappuoli, R. (2012). Reverse vaccinology in the 21st century: improvements over the original design. Annals of New York Academy of Sciences, 285, 115-132.
[5] Fleischmann, R. D., Adams, M. D., White, O., Clayton, R. A., Kirkenes, E. F., Kerlavage, A. R., et al. (1995). Whole-genome random sequencing and assembly of Haemophilus influenza Rd. Science, 269, 496-512.
[6] Pizza, M., Scarlato, V., Masignani, Giuliani M. M., Arico, B., Comanducci, M., et al. (2000). Identification of vaccine candidates against serogroup B meningococcus by whole genome sequencing. Science, 287, 1816-1820.
[7] Boerno, S. T., Grimm, C., Lehrach, H., and Schweiger, M. R. (2010). Next-generation sequencing technologies for DNA methylation analyses in cancer genomics. Epigenomics, 2, 199-207.
[8] Nobuta, K., McCormick, K., Nakano, M., Meyers, B. C. (2010). Bioinformatics analysis of small RNA in plants using next generation sequencing technologies. Methods in Molecular Biology, 591, 89-106.
[9] Tettelin, H., Saunders, N. J., Heidelberg, J., Jeffries, A. C., Nelson, K. E., Eisen, J. A., et al. (2000). Complete genome sequence of Neisseria meningitides serogroup B strain MC58. Science, 287, 1809-1815.
[10] Giuliani, M. M., Adu Bobie, J., Comanducci, M., Arico, B., Savino, S., Santini, L., et al. (2006). A universal vaccine for serogroup B Meningococcus. Proceedings of the National Academy of Sciences USA, 103, 10834-10839.
[11] Michalik, M., Djahanshiri, B., Leo, J. C., and Linke, D. (2016). Reverse Vaccinology: The pathway from genomes and epitope predictions to tailored recombinant vaccines. Methods in Molecular Biology, 1403, 87-106.
[12] Rappuoli, R. and Aderem, A. (2011). A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature, 473,463-466.
[13] Giasuddin, A. S. M., Jhuma, K. A., and Haq, A. M. M. (2018). Reverse vaccinology: Modern challenges in vaccine design and development. Journal of the Medical College for Women and Hospital, 16(1&2), 23-25.
[14] Tettelin, H., Riley, D., Cattuto, C., and Medini, D. (2008). Comparative genomics: the bacterial pangenome. Current Opinion in Microbiology, 11,472-477.
[15] Berlanda Scorza F., Doro, M., Rodriguez-Ortega, M. J., Stella, M., Liberatori, S., Taddei, A. R., et al. (2008). Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic Escherichia coli DeltatorIR IHE3034 mutant. Molecular and Cell Proteomics, 7, 473-485.
[16] Stern-Ginossar, N., Weisburd, B., Michalski, A., Li, V. T. K., Hein, M. V., Huang, S.-X., et al. (2012). Decoding human cytomegalovirus. Science, 338, 1088-1093.
[17] Cheng, L., Lu, W., Kulkarni, B., Pejovic, T., Yan, X., Chiang, J.-H., et al. (2010). Analysis of chemotherapy response programs in ovarian cancers by the next-generation sequencing technologies. Gynecology and Oncology, 117, 159-169.
[18] Contreras, M., Villar, M., Artigas-Jerónimo, S., Kornieieva, L., Mуtrofanov, S., de la Fuente, J. (2018). A reverse vaccinology approach to the identification and characterization of Ctenocephalides felis candidate protective antigens for the control of cat flea infestations. Parasites and Vectors, 11(1), 43. doi: 10.1186/s13071-018-2618-x.
[19] Dalsass, M., Brozzi, A., Medini, D., and Rappuoli, R. (2019). Comparison of Open-Source Reverse Vaccinology Programs for Bacterial Vaccine Antigen Discovery. Frontiers in Immunology, 10, 113. DOI: 10.3389/fimmu. 2019.00113.
[20] Wu, Z. and McGrogen, J. M. (2020). Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China. Journal of American Medical Association, 323(13), 1239-1242. doi:10.1001/jama.2020.2648.
[21] Dayarathana, S., Jeewandara, C., Gomes, L., Somathilaka, G., Jayathilaka, D., Vimalachandran, V., et al. (2020). Similarities and differences between the cytokine storms in acute dengue and COVID-19. Research Square, doi: https://doi.org/10.21203/rs.3.rs-39133/vi.
[22] Gupta, E., Mishra, R. K., and Niraj, R. R. K. (2020). Identification of potential vaccine candidates against SARS-CoV-2, a step forward to fight COVID-19: A reverse vaccinology approach. bioRxiv, DOI: http://doi.org/10.1101/2020.04.13.039198 (Re-trieved 16 June 2021).
[23] Enayatkhani, M., Hasaniazad, M., Faezi, S., Gouklani, H., Davoodian, P., Ahmadi, N., et al. (2021). Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: An Insilco study. Journal of Biomolecular Structure and Dynamics, 39(8), 2857-2872. doi: 10.1080/07391102.2020.1756411.
[24] Bansal, A., Padappayil, R. P., Garg, C., Singal, A., Gupta, M., Klein, A. (2020). Utility of artificial intelligence amidst the COVID 19 pandemic: A review. Journal of Medical Systems, 44: 156. Available from: https://doi.org/10.1007 /s10916-020-01617-3.
[25] Chen, W. (2020). Promise and challenges in the development of COVID-19 vaccines. Human Vaccines & Immunotherapeutics, 16(11), 2604-2608. doi:10.1080/21645515.2020.1787067. Available from: https://doi.org/10.1080/21645515.2020.1787067.
[26] Burton, D. R. and Walker, L. M. (2020). Rational vaccine design in the time of COVID-19. Cell Host & Microbe, 27 (5), 695-698. Available from: https://doi.org/10.1016/j.chom.2020.04.022.
[27] Wikipedia. COVID-19 vaccine. Available from: https://en.m.wikipedia.org/wiki/COVID 19 Vaccine. (Accessed on 05 December 2020)
[28] www.cepi.net. Newvaccines for a safer world. CEPI 2020. (Retrieved 15 December 2020)
[29] www.cept.net. CEPI’s COVID-19 vaccine portfolio. CEPI 2020 (Retrieved 15 December 2020)
[30] Rappuoli, R., Bottomley, M. J., D’Oro, U., Finco, O., De Gregorio, E. (2016). Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design. Journal of Experimental Medicine, 213(4), 469-481. Available from:www.jem.org/cgi/doi/10.1084/jem.20151960.